Future students

Course search


Unit details

Return to previous page

HMM302 - Innovations in Medical Biotechnology

Enrolment modes:

Trimester 1: Waurn Ponds (Geelong)

Credit point(s):1
EFTSL value:0.125
Unit chair:

Paul Lewandowski



Contact hours:

3 x 1 hour classes per week and 1 x 1 hour seminar per week


You will need to access substantial learning resources and experiences in CloudDeakin (Deakin’s online learning environment). Compliance with the Standards in computing, connectivity and student capability are a condition on your enrolment.


This unit provides a comprehensive overview of the business of medical biotechnology, including innovation management, funding, and the regulatory framework relevant to the industry. It will also explore risk management, and the societal and ethical issues pertinent to medical biotechnology in real-world scenarios.


Assessment task 1: Written report 1 (800 words) 20%

Assessment task 2: Written report 2 (800 words) 20%

Assessment task 3: Written report 3 (800 words) 20%

Assessment task 4: Examination (2 hours) 40%

Prescribed texts

Crommelin, D. J. A., Sindelar R. D., Meibohm, B. 2008. Pharmaceutical Biotechnology: Fundamentals and Applications, 3rd edn, Informa Healthcare, New York, US

Unit Fee Information

Student Contribution Rate*Student Contribution Rate**Fee rate - Domestic Students Fee rate - International students

* Rate for all CSP students, except for those who commenced Education and Nursing units pre 2010
** Rate for CSP students who commenced Education and Nursing units pre 2010
Please note: Unit fees listed do not apply to Deakin Prime students.

Return to previous page

Deakin University acknowledges the traditional land owners of present campus sites.

8th June 2007